Spots Global Cancer Trial Database for Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

Official Title: EROS 3 Study Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy Brachytherapy in Terms of Overall Toxicity and Sexual Activity

Study ID: NCT06398938

Conditions

Locally Advanced Cervical Carcinoma

Interventions

Interventional Radiotherapy

Study Description

Brief Summary: To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

Detailed Description: Observational, monocentric and prospective study. All patients with locally advanced cervix cancer will be underwent to radiochemotherapy followed by accelerated interventional radiotherapy (brachytherapy). Fist endpoints wer severe acute and late gastrointestinal, and urinary toxicities and sexual activity.